hydroxypropyl cellulose

FDA Drug Profile — Lacrisert

Drug Details

Generic Name
hydroxypropyl cellulose
Brand Names
Lacrisert
Application Number
NDA018771
Sponsor
Bausch & Lomb Incorporated
NDC Codes
2
Dosage Forms
INSERT, PELLET
Routes
OPHTHALMIC
Active Ingredients
HYDROXYPROPYL CELLULOSE (1600000 WAMW)

Indications and Usage

INDICATIONS AND USAGE LACRISERT is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with: Exposure keratitis Decreased corneal sensitivity Recurrent corneal erosions

Warnings

WARNINGS Instructions for inserting and removing LACRISERT should be carefully followed.